This content is provided by Chambers. Learn more about our methodology
What the team is known for Sought for its in-depth expertise in FDA regulatory matters at state, federal and international level, including advisory work for clients regarding compliance with the Food Safety Modernization Act. Demonstrates notable proficiency in a variety of specialized technical matters including biotechnology issues, food contaminants and ingredient safety. Significant experience in representing national and international manufacturers and ingredient suppliers. Regularly handles food compliance issues associated with significant deals and foodborne illness cases. Major clients include Coca-Cola and Nestlé Nutrition.
Strengths Sources report: "Their skills complement each other. They are very well networked at the FDA and they have a good regulatory shop."
Another interviewee adds: "I would describe the quality of service as excellent. Their strengths include being proactive business partners. They also don't wait for issues to arise but are looking out for their clients for what might arise. They're very good team players. They're efficient and enjoyable to work with."
One impressed client says: "I appreciate the firm's thoughtfulness and common-sense approach to addressing complex legal issues."
Work highlights Represented Cal-Maine Foods in Palmer v. Cal-Maine Foods, a case relating to the allegedly false and misleading labeling of Wal-Mart eggs.
Frederick Degnan is held in high regard in the food and beverages space and receives praise for his wealth of experience. He provides counsel to multinationals and industry associations on a wide spectrum of issues including foodborne illness investigations, labeling matters and liaison with the FDA.
Smitha Stansbury is frequently sought out by food manufacturers and industry groups for her deep knowledge of FDA regulation. She is also a popular choice for clients seeking advice on an array of labeling and food safety matters. Clients value her for being "very sharp and customer-oriented" and commend her "expertise in FDA and regulatory matters."